Healthcare U.S. Community

Spectral AI is building a tool that helps doctors spot which wounds are likely to heal and which ones need faster, more serious care, including burns that can be hard to judge by eye. The big question is whether regulators sign off and whether hospitals and emergency rooms turn early interest into real orders before cash runs tight.Read more

BrightSpring’s growth story may look like home health at first glance, but the real engine is its specialty and long-term care pharmacy business, where patients rarely switch providers once treatment starts. As the company finishes cleanup work from past restructuring, improving efficiency and lower debt could change how the market views the business.Read more

The Hook: A Massive Valuation Disconnect While the market has pinned NexGel (NXGL) to its 52-week lows near $0.58 , the underlying business has just undergone a fundamental "rebirth." According to Simply Wall St’s intrinsic value model, the stock is currently 86.5% undervalued , with a fair value estimate of $4.30. This creates a rare setup where the market cap ($5M) is significantly lower than the company's projected annual revenue.Read more

In a nutshell: Hims & Hers has invested heavily and benefits are starting to show through growth and expansion. Investing continues with steps taken with a clear long term goal on the background, to be a front door for customers, the delivery channel, the platform and ecosystem.Read more

$BLCO & $COO. The Silence After the AGM: A Retail Investor’s Timeline, Findings, and Opinion on an Unprecedented Governance Failure By a Retail Investor and Portfolio Manager (Opinion) --- I.Read more

Lucid Diagnostics' EsoGuard is a novel screening tool for esophageal cancer. It is relatively non-invasive and may become widely accepted soon.Read more

I have followed ISRG since 2003 when it was brought to the investing club I had just joined. I tried to analyze ISRG with the BetterInvesting SSG methodology that I had been introduced to and I could not get it in the buy zone.Read more

RxSight (NASDAQ: RXST), maker of the only cataract lens that can be adjusted post-surgery, could be undervalued by an eye-popping margin More than 70% of RxSight Light Adjustable Lens (LAL) patients reported 20/20 or better vision after receiving the lens. Only 36.3% of non-adjustable lens patients reported the same.Read more

COMPANY ANALYSIS : Hims & Hers is a telehealth company founded in 2017 with the mission of improving wellness through accessible healthcare. The company operates primarily in the United States, Canada and Europe growing largely through the acquisition of the telehealth platform ZAVA, planning on further international growth.Read more